Drugs / Peptide (neoantigen) pulsed autologous Dendritic cell
Peptide (neoantigen) pulsed autologous Dendritic cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06195618 | Aug 2025 → Jun 2027 expected | female breast carcinoma | National University of Colombia | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peptide (neoantigen) pulsed autologous Dendritic cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06195618 ↗ |
| Modality | Cell therapy | “peptide-pulsed autologous dendritic cells” NCT06195618 ↗ |